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Abstract
Background: We recently demonstrated that tyrosine sulfation is an important contributor to monocyte recruitment and
retention in a mouse model of atherosclerosis. P-selectin glycoprotein ligand-1 (Psgl-1) is tyrosine-sulfated in mouse
monocyte/macrophages and its interaction with P-selectin is important in monocyte recruitment in atherosclerosis.
However, whether tyrosine sulfation is required for the P-selectin binding function of mouse Psgl-1 is unknown. Here we
test the function of native Psgl-1 expressed in leukocytes lacking endogenous tyrosylprotein sulfotransferase (TPST) activity.
Methodology/Principal Findings: Psgl-1 function was assessed by examining P-selectin dependent leukocyte rolling in
post-capillary venules of C57BL6 mice transplanted with hematopoietic progenitors from wild type (WTRB6) or Tpst1;Tpst2
double knockout mice (Tpst DKORB6) which lack TPST activity. We observed that rolling flux fractions were lower and
leukocyte rolling velocities were higher in Tpst DKORB6 venules compared to WTRB6 venules. Similar results were
observed on immobilized P-selectin in vitro. Finally, Tpst DKO leukocytes bound less P-selectin than wild type leukocytes
despite equivalent surface expression of Psgl-1.
Conclusions/Significance: These findings provide direct and convincing evidence that tyrosine sulfation is required for
optimal function of mouse Psgl-1 in vivo and suggests that tyrosine sulfation of Psgl-1 contributes to the development of
atherosclerosis.
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Introduction
Atherosclerosis is a chronic inflammatory disease of the arterial
wall [1,2]. It is initiated by vascular endothelial injury that leads to
endothelial dysfunction and intramural accumulation of oxidized
LDL. This causes the elaboration of signalling molecules and
induction of adhesion receptors that promotes recruitment of
monocytes into the vessel wall, a dominant factor in the initiation
and progression of atherosclerosis [3].
We recently examined the importance of tyrosine sulfation in
the development of atherosclerosis in a model in which lethally-
irradiated Ldlr2/2 mice were rescued with hematopoietic
progenitors lacking tyrosylprotein sulfotransferase (TPST) activity
[4]. We observed substantial reductions in aortic root lesion size
and the number of macrophages in lesions in hyperlipidemic
Ldlr2/2 recipients transplanted with TPST deficient progenitors
compared to controls. These data indicate that tyrosine sulfation of
one or more proteins expressed in hematopoietic cells has a major
impact on the development of atherosclerosis. The identities and
the relative importance of the tyrosine-sulfated proteins involved
are unknown. However, P-selectin glycoprotein ligand-1 (Psgl-1),
along with the chemokine receptors Ccr2, Ccr5, and Cx3cr1 are
likely candidates [4,5].
Psgl-1 is a homodimeric mucin that is broadly expressed on
hematopoietic cells [6]. In mice lacking P-selectin or Psgl-1,
leukocyte rolling is virtually absent in a model of trauma induced
P-selectin expression in post-capillary venules [7,8]. Thus, Psgl-1 is
the major physiologic ligand for P-selectin [9]. Psgl-1 is also a key
player in the development of atherosclerosis. Psgl-1 expressed on
Ly-6C
hi monocytes is a major mediator of monocyte recruitment
into atherosclerotic lesions in mice, and aortic root lesions are
<40% smaller in hyperlipidemic ApoE2/2; Selplg2/2 mice
compared to ApoE2/2 mice [10]. In addition, transient P-selectin
or Psgl-1 blockade using mAbs reduces macrophage influx and
neointima formation in a model of arterial injury in ApoE2/2
mice [11].
Structure-function relationships for human PSGL-1 have been
defined in great detail. The P-selectin binding site spans <15
residues near the N-terminus of the mature polypeptide, it
contains sulfotyrosine residues at positions 5, 7, and 10 and a
core 2 O-glycan terminating with sialyl-Le
x linked to Thr16
[12,13,14,15]. Together these structural features are both
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mouse Psgl-1 the structure-function relationships are not as clearly
defined. Like human PSGL-1, the P-selectin binding site of mouse
Psgl-1 is near the N-terminus as defined by function blocking
mAbs, but its amino acid sequence is considerably different than
that of human PSGL-1 (Fig. 1) [16,17].
Mouse Psgl-1 has two threonine residues (Thr14 and Thr17)
near the N-terminus that are possible sites for O-glycan addition.
P-selectin dependent rolling is severely impaired in fucosyltrans-
ferase VII (FucTVII) and core 2 b(1,6)-N-acetylglucosaminyl-
transferase-I (C2GlcNAcT-I) deficient mice indicating that mouse
Psgl-1 requires a(1,3)fucosylated, core 2 O-glycan for optimal P-
selectin binding in vivo [18,19]. Furthermore, mouse Psgl-1
endogenously expressed in murine WEHI-3 cells carries core 2 O-
glycan capped with sialyl-Le
x and site-directed mutagenesis studies
implicate Thr17 as a site of O-glycan addition [20,21].
In contrast to the substantial evidence for the importance of O-
glycosylation, the importance of tyrosine sulfation of mouse Psgl-1
for P-selectin binding has not been definitely demonstrated.
Indeed, it was only recently that mouse Psgl-1 was shown to be
tyrosine-sulfated [4]. Tyr13 and Tyr15 are the only possible
sulfation sites because they are the only tyrosine residues in the
extracellular domain. The only study addressing the potential
importance of tyrosine sulfation for mouse Psgl-1 is that of Xia et
al who examined the function of recombinant mouse Psgl-1
expressed in Chinese hamster ovary (CHO) cells stably expressing
human FucTVII and human C2GlcNAcT-I in vitro [21]. They
observed that TyrRPhe substitution at position 13, but not at
position 15, impaired P-selectin binding and rolling of CHO cells
on P-selectin in vitro, suggesting that Tyr13 was sulfated.
However, the authors noted that their results should be interpreted
cautiously because amino acid substitutions might impair function
indirectly.
We therefore sought to directly examine the functional
importance of tyrosine sulfation of native mouse Psgl-1 by testing
its function in leukocytes lacking endogenous TPST activity in
vivo. To accomplish this, mice were transplanted with hemato-
poietic progenitors from mice lacking both the Tpst1 and Tpst2
genes, the only TPSTs expressed in mice, and the rolling
behaviour of TPST deficient leukocytes was examined in well-
characterized, physiologically relevant assays. We found that
TPST deficient leukocytes roll on P-selectin in vivo and in vitro.
However, rolling of TPST deficient leukocytes was less efficient




All procedures involving vertebrate animals were reviewed and
approved by the Institutional Animal Care and Use Committee at
the Oklahoma Medical Research Foundation (Protocol #W0070).
Antibodies
PE-conjugated anti-mouse Psgl-1 mAb 2PH1 (rat IgG1-k), anti-
mouse Psgl-1 mAb 4RA10 (rat IgG1-k), FITC-CD45.1 mAb A20
(mouse IgG2A-k), PE-CD45.2 mAb 104 (mouse IgG2A-k), anti-
mouse P-selectin mAb RB40.34 (rat IgG1-l), and anti-mouse
CD16/CD32 mAb 2.4G2 (rat IgG2B-k, Mouse BD Fc Block
TM)
were from BD Pharmingen. Anti-mouse Psgl-1 mAb 4RB12 (rat
IgG2A) was provided by Dietmar Vestweber (Max Planck Institute
for Molecular Biomedicine, Mu ¨nster, Germany). Goat anti-mouse
CD16/CD32 polyclonal antibody was from R&D Systems.
Hematopoietic transplantation
Tpst1;Tpst2 double knockout (Tpst DKO) mice were generated
and characterized as previously described [22,23]. These mice
have severely impaired post-natal viability. Therefore, fetal livers
were used as the source of hematopoietic progenitors. Lethally-
irradiated B6.SJL-Ptprc
a Pep3
b/BoyJ recipients (B6.SJL, The
Jackson Laboratory, Stock #002014) were transplanted with
E15.5 fetal liver cells from wild type 129S6 or Tpst DKO mice,
which are in the 129S6 background as described previously [4].
These groups are abbreviated as WTRB6 and Tpst DKORB6,
respectively. All studies were conducted 16–24 weeks after
transplantation. Complete blood counts were determined at the
time of experimentation as previously described [4].
Intravital microscopy
Mice were anesthetized, placed on a warmed microscope stage,
and a catheter was placed in the left carotid artery for injections
and blood sampling. Exteriorization of the cremaster muscle was
used to induce P-selectin-dependent leukocyte rolling [24,25]. The
cremaster muscle was mounted on an observation portal and
continuously bathed with Hank’s balanced salt solution or
131.9 mM NaCl, 18 mM NaHCO3, 4.7 mM KCl, 2.0 mM
CaCl2 and 2 mM MgSO4, pH 7.2 equilibrated with 79% N2
and 16% CO2 and 5% O2 at 36uC. All data collection was
completed within 20 min of exteriorization of the cremaster
muscle.
Observations of post-capillary venules were made using a Nikon
Eclipse E600-FN microscope equipped with a water immersion
objective (40x/0.80 W). Images were recorded using a CCD
camera (DC-330E, Dage-MTI) and centerline velocities (vCL) were
measured using an optical doppler velocimeter (Microvessel
Velocity OD-RT, CircuSoft Instrumentation). Vessel diameter
and the distance leukocytes rolled were determined from recorded
images using a digital image processing system (SGI O2
workstation running Inovision ISEEH v5.24 software) and freeze-
frame advancing.
Rolling flux fractions were calculated by dividing leukocyte
rolling flux, defined as the number of rolling leukocytes passing a
line perpendicular to the vessel axis over a period of 1 min, by
total leukocyte flux estimated as WBC N vb N p N (d/2)
2, where WBC
is total leukocyte count, vb is mean blood flow velocity (vCL N 0.625)
and d is vessel diameter [26]. Rolling velocities for 10 leukocytes
passing a line perpendicular to the vessel axis were measured in the
same venules as rolling flux fractions. Leukocytes were analyzed
for a period of 1 s (30 frames). Mean rolling velocity was calculated
by dividing the distance travelled by the elapsed time.
Leukocyte interaction with the vessel wall was considered as
rolling and not free flowing when velocities were below the critical
velocity estimated as vcrit =v b N e N (2 - e), where e is the ratio of the
leukocyte diameter to vessel diameter [27]. The leukocyte
diameter is taken to be 7 mm [28]. Wall shear rates (cw) were
estimated as cw =4.9 (8 vb /d) where 4.9 is a correction factor
Figure 1. Sequence alignment of the N-terminal P-selectin
binding sites of human and mouse P-selectin glycoprotein
ligand-1.
doi:10.1371/journal.pone.0020406.g001
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image velocimetry in microvessels [29,30,31].
Parallel plate rolling assays
Polystyrene 35-mm dishes were coated with anti-human IgM Fc
mAb (20 mg/ml, clone MH15-1, Accurate Chemical & Scientific)
in HBSS overnight at 4uC. Dishes were washed with HBSS, 0.1%
human serum albumin (HSA), blocked with HBSS, 1% HSA for
2 h and then incubated for 1 h at 37uC with media from COS-7
cells transfected with plasmids encoding mouse P-selectin/IgM or
mouse CD45/IgM chimera. The plasmids were from by John B.
Lowe (University of Michigan) and the conditioned media was
kindly provided by Dr. Lijun Xia and John Michael McDaniel
(Oklahoma Medical Research Foundation). P-selectin site densities
were determined using
125I-labeled RB40.34 [32]. In some
experiments dishes were pre-incubated with blocking P-selectin
mAb RB40.34 (20 mg/ml, 1 h).
Bone marrow cells were flushed from femurs and passed through
a4 0mm filter. Erythrocytes were lysed and cells were pelleted and
resuspended in HBSS, 0.5% HSA at 0.5610
6 cells/ml. Cells were
drawn through a parallel plate flow chamber (GlycoTech) using a
PHD 200 syringe pump (Harvard Apparatus). Rolling leukocytes
wereobserved using a Zeiss Axiovert 200 microscopeequipped with
a 20x/0.3 Ph1 objective. After 5 minutes, images were recorded
using a CCD camera (XC-77, Hamamatsu Photonics) and analyzed
using the image processing system described above. For each
experiment, rolling leukocytes were analyzed in 4 fields in a vertical
line perpendicular to the direction of flow. The number of rolling
cells was converted to cells/mm
2 and the mean rolling velocities of
10 cells in each field were calculated by dividing the distance
travelled by the elapsed time.
Flow cytometry
The degree of donor hematopoiesis in B6.SJL recipients
(CD45.1
+) transplanted with wild type or Tpst DKO (CD45.2
+)
hematopoietic cells was assessed by flow cytometry. Leukocytes
were collected from bone marrow or peripheral blood into 2 mM
EDTA. Erythrocytes were lysed and cells were pelleted and
resuspended in HBSS, 1% FBS, 0.02% NaN3. Cells were incubated
in mouse Fc block (10 mg/ml) followed by FITC-CD45.1 (10 mg/
ml) and PE-CD45.2 (10 mg/ml). Following washing, cells were fixed
with 1% paraformaldehyde in HBSS, 0.02% NaN3 and analyzed in
a FACSCalibur
TM flow cytometer (Becton Dickinson).
To quantitate Psgl-1 surface expression, cells were incubated
with goat anti-mouse Fc block followed by PE-2PH1 (5 mg/ml) or
4RB12 (5 mg/ml) followed by FITC rabbit anti-rat IgG (10 mg/ml,
Vector Labs). To assess P-selectin binding, cells were incubated
with mouse P-selectin/IgM or control CD45/IgM and bound
chimera was detected with FITC goat anti-human IgM (10 mg/ml,
Chemicon). Analyses were gated on the neutrophil and monocyte
population of donor (CD45.2
+) origin. In some experiments,
blocking mAbs against mouse P-selectin (RB40.34, 20 mg/ml) or
mouse Psgl-1 (4RA10, 30 mg/ml) were included.
Statistical Analysis
Differences in rolling velocity and rolling flux fraction were
determined using independent samples t-tests using SPSS (SPSS
for Mac, rel. 18.0). In addition to the p-values for the t-test, we
present the effect size, Cohen’s d, which measures the magnitude
of the difference between the two group means expressed in terms
of standard deviation. A Cohen’s d value $0.8 represents a large
effect size [33]. All tests were two-tailed and an a #0.05 was set for




To assess the efficiency of reconstitution of Tpst DKO hemato-
poiesis in B6.SJL recipients, complete blood counts and the
percentage of donor (CD45.2
+) cells were determined at the time of
experimentation at 16–24 weeks after transplantation. We observed
that the total leukocyte, neutrophil, lymphocyte, monocyte, erythro-
c y t ea n dp l a t e l e tc o u n t sw e r en o r m a la n dt h a tt h e r ew e r en o
significant differences between the two transplant groups (Table 1).
For in vivo rolling and P-selectin binding studies using
peripheral blood, 96.260.7% (n=10) of circulating neutrophils
and monocytes in WTRB6 mice and 94.761.2% (n=17) in Tpst
DKORB6 mice were CD45.2
+ at the time of experimentation.
For in vitro rolling and P-selectin binding studies using bone
marrow leukocytes, 97.460.5% (n=4) of bone marrow leukocytes
in WTRB6 mice and 96.561.2% (n=6) in Tpst DKORB6 mice
were CD45.2
+ at the time of experimentation.
Mice appeared normal with no clinical signs of graft vs. host disease
(i.e. diarrhea). Furthermore, body weights of the WTRB6 group
(22.060.4 g, n=13) were similar to the Tpst DKORB6 group
(23.160.5 g, n=13). Taken together, these data demonstrate efficient
reconstitution of donor hematopoiesis in the B6.SJL recipients,
confirming the histocompatibility of the donor-recipient pair.
P-selectin-dependent leukocyte rolling in vivo
P-selectin-dependent leukocyte rolling in post-capillary venules
was induced by exteriorization of the cremaster muscle. Rolling
flux fractions were quantitated in 49 venules in 7 WTRB6 mice
and 39 venules in 7 Tpst DKORB6 mice and leukocyte rolling
velocities were determined for an average of 8.5 rolling cells in
each venule (Fig. 2A and B). Hemodynamic and microvascular
parameters including venule diameter, centerline velocity and wall
shear rates were comparable in WTRB6 and Tpst DKORB6
mice (Table 2).




















WTRB6 4.8760.76 1.2860.17 3.2160.57 0.3060.08 8.3860.25 645658
Tpst DKORB6 5.6460.70 1.2560.19 3.9860.47 0.3060.08 7.8260.28 632656
p-value 0.461 0.896 0.304 0.973 0.152 0.872
Complete blood counts 16–24 weeks post-transplant are expressed as the mean 6 S.E.M. (n=13). Statistical differences between the groups were assessed using a
Student’s two-tailed t-test with unequal sample variance.
doi:10.1371/journal.pone.0020406.t001
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DKORB6 venules (8.361.1%, n=39 venules) compared to
WTRB6 venules (18.061.8%, n=49 venules). We also observed
that leukocyte rolling velocities were higher in Tpst DKORB6
venules (88.664.8 mm/s) compared to WTRB6 venules
(33.161.8 mm/s). Statistical analysis showed that rolling flux
fraction in Tpst DKORB6 venules were significantly lower
(p,0.0001, d=0.96) and rolling velocities were significantly higher
in the Tpst DKORB6 group compared to the WTRB6 group
(p,0.0001, d=2.4).
In some experiments, blocking mAbs to P-selectin or Psgl-1
were administered after initial data collection and venules were re-
examined for rolling leukocytes. In each of these experiments
observations were made before and immediately after mAb
administration in a single venule and then in an additional 2–7
venules in each animal. We observed that rolling leukocytes,
defined as those with velocities less than vcrit, were undetectable
after administration of 10 mg of P-selectin mAb RB40.34 in both
WTRB6 and Tpst DKORB6 mice (n=3). In a separate series of
experiments, rolling leukocytes were also undetectable in WTRB6
and Tpst DKORB6 mice (n=3) after administration of 10 mgo f
Psgl-1 mAb 4RA10.
P-selectin-dependent leukocyte rolling in vitro
To study P-selectin-dependent rolling in a more defined system,
leukocyte rolling was observed on P-selectin coated dishes in a
parallel plate flow chamber. The number of rolling leukocytes and
leukocyte rolling velocities were quantitated in three independent
experiments comparing leukocytes harvested from wild type and
Tpst DKORB6 mice. Bone marrow leukocytes were harvested
and drawn over dishes coated with mouse P-selectin/IgM at a
shear stress of 1 dyn/cm
2 as described in Methods.
For wild type leukocytes, we observed 176615 rolling cells/
mm
2, whereas for Tpst DKORB6 leukocytes we observed only
9766 rolling cells/mm
2 (n=12 fields from 3 independent paired
experiments) (Fig. 3A). Statistical analysis showed that the number
of rolling cells in the Tpst DKORB6 group was significantly lower
than the WT group (p,0.0001, d=2.1).
Inthesame experiments,the velocitiesof10individualleukocytes
in each of the 4 fields observed were measured. We found that wild
type leukocytes rolled with a mean velocity of 1.660.1 mm/s. In
contrast, Tpst DKORB6 leukocytes had mean rolling velocities of
2.460.1 mm/s (Fig. 3B). Statistical analysis showed that rolling
velocities were significantly higher in the Tpst DKORB6 group
compared to the WT group (p,0.0001, d=2.3). No detectable
leukocyte rolling was observed on dishes coated with mouse CD45/
IgM or when dishes coated with P-selectin/IgM were pre-incubated
with the P-selectin blocking mAb RB40.34 (data not shown).
P-selectin binding and Psgl-1 expression
P-selectin binding to Psgl-1 on neutrophils in peripheral blood
was determined using flow cytometry. Neutrophils were gated
based on their forward and orthogonal light scattering properties
and on donor origin (CD45.2
+). We observed that the mean
fluorescence intensity (MFI) of P-selectin binding to WTRB6 cells
was 1,3226138 (n=3) and 557664 for Tpst DKORB6 cells
(n=7) (Fig. 4A & B). This difference is highly significant
(p=0.016). Pre-incubation of cells with P-selectin blocking mAb
RB40.34 or Psgl-1 blocking mAb 4RA10 completely blocked
binding of the P-selectin/IgM to levels equivalent to that for
CD45/IgM (data not shown).
These samples were also analyzed by flow cytometry using the
Psgl-1 blocking mAb 2PH1, to investigate whether the reduced
rolling of Tpst DKO cells and reduced binding of P-selectin to Tpst
DKO neutrophils was due to altered surface expression of Psgl-1.
We observed that MFI of 2PH1 binding to neutrophils from
WTRB6 mice (3,4886169, n=3) and Tpst DKORB6 mice were
indistinguishable (3,3226123, n=7, p=0.47) (Fig. 4C & D). We
also examined Psgl-1 expression on leukocytes from a rare Tpst
DKO mouse at post-natal day 14 using 4RB12, a non-blocking
antibody to Psgl-1. 4RB12 binding to peripheral blood neutrophils
and bone marrow leukocytes from the Tpst DKO mouse was
indistinguishable from an age-matched wild type mouse examined
in parallel (data not shown).
Discussion
We recently reported that transplantation of Ldlr2/2 mice with
Tpst DKO hematopoietic progenitors drastically attenuated
Figure 2. P-selectin dependent rolling in vivo. Surgical exterior-
izationof thecremaster muscle was used to induceP-selectin-dependent
leukocyte rolling in post-capillary venules. (A) The rolling flux fraction in
49 venules from 7 WTRB6 mice and 39 venules from 7 Tpst DKORB6
mice was determined. (B) Mean rolling velocities were determined from
an average of 8.5 leukocytes/venule in the same venules as the rolling
flux fractions. All values are reported as mean 6 S.E.M.
doi:10.1371/journal.pone.0020406.g002













WTRB6 7 49 30.061.0 1369686 949666
Tpst DKORB6 7 39 29.961.1 1123685 12296104
Values are expressed as the mean 6 S.E.M.
doi:10.1371/journal.pone.0020406.t002
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tyrosine sulfation of one or more proteins expressed in hemato-
poietic cells has a major impact on the development of
atherosclerosis. Psgl-1 is one likely candidate because it is known
to be tyrosine-sulfated in the mouse and its role in monocyte
recruitment in atherosclerosis is well established [4,10,11]. We
therefore sought to directly examine the functional importance of
tyrosine sulfation for Psgl-1 in vivo.
To address this question, mice were transplanted with
hematopoietic progenitors from mice lacking endogenous TPST
activity and the rolling behaviour of TPST deficient leukocytes
was examined in a well-characterized model of trauma induced P-
selectin expression in post-capillary venules in the cremaster
muscle. We observed that significantly fewer TPST deficient
leukocytes rolled in post-capillary venules in the Tpst DKORB6
group compared to wild type leukocytes in the WTRB6 group
and TPST deficient leukocytes rolled at significantly higher
velocities than wild type leukocytes. These observations were
confirmed in two well-defined in vitro assay systems. First, in a
parallel plate adhesion assay, fewer TPST deficient leukocytes
rolled on P-selectin and they rolled at higher velocities compared
to wild type leukocytes under physiologically relevant shear stress.
In addition, in a flow cytometry assay, binding of fluid-phase P-
selectin to TPST deficient peripheral blood and bone marrow
leukocytes was significantly lower than binding to wild type
leukocytes. Importantly, we showed that impaired rolling in vivo
and in vitro and impaired binding of fluid-phase P-selectin to
TPST deficient leukocytes was not due to differences in surface
expression of Psgl-1. Finally, antibody blocking experiments in
Tpst DKORB6 mice showed that anti-Psgl-1 mAb abolished P-
selectin dependent rolling in vivo. Taken together these observa-
tions demonstrate that tyrosine sulfation enhances the binding
capacity of mouse Psgl-1, but is not an absolute requirement for
Psgl-1 function in vivo. These findings, in conjunction with our
previous report that atherosclerosis is attenuated in hyperlipidemic
Ldlr2/2 mice with Tpst DKO hematopoiesis, suggest that
tyrosine sulfation of Psgl-1 may contribute to lesion development.
It is formally possible that impaired rolling of TPST deficient
leukocytes is due to differences in O-glycosylation of Psgl-1
compared to wild type leukocytes. However, it is difficult to
envision how O-glycosylation, that occurs in an earlier Golgi
compartment, could be impacted by the presence or absence of
tyrosine sulfation that occurs in the trans-Golgi network [34,35].
In our studies, leukocyte rolling was completely abrogated by
injection of a blocking P-selectin antibody. This is consistent with
published data that leukocyte rolling in this model is entirely
dependent on P-selectin expression on the post-capillary venules
[25]. Psgl-1 is the predominant ligand for P-selectin is the early
phases (,30 min) after trauma-induced inflammation in the
mouse cremaster. However, previous studies indicate that a minor
component of P-selectin-dependent rolling in this model is Psgl-1-
independent [16,19,36,37]. For example, Yang et al reported that
rolling flux fraction was severely reduced but detectable in Psgl-1
deficient animals (1.2%) compared wild type controls (20.9%) [8].
In addition, Sperandio et al reported that administration of the
anti-Psgl-1 mAb 4RA10 to wild type mice reduced rolling flux
fraction from 27% to 8% and increased rolling velocities from 44
to 110 mm/sec. In our study, rolling was abolished by 4RA10 in
both WTRB6 and Tpst DKORB6 mice. Thus, we do not detect a
Psgl-1-independent component of P-selectin-dependent rolling
that has been reported by others.
Our findings provide strong support for previous in vitro
observations by Xia et al, who examined the effects of site-directed
mutagenesis and sodium chlorate on mouse Psgl-1 function in
CHO cells stably expressing human FucT-VII and C2GlcNAcT-I
Figure 3. P-selectin dependent leukocyte rolling in vitro. Bone
marrow leukocytes from wild type (n=3) and Tpst DKORB6 (n=3) mice
were isolated and their rolling on immobilized mouse P-selectin/IgM
(site density =100 sites/mm
2) was observed at 1 dyn/cm
2. (A) For each
animal, the number of rolling cells in 4 fields of view were averaged. (B)
Rolling velocities of 10 leukocytes were determined in the same 4 fields
of view as the number of rolling cells. Values are reported as mean 6
S.E.M.
doi:10.1371/journal.pone.0020406.g003
Figure 4. Binding of fluid-phase P-selectin and Psgl-1 expres-
sion. Binding of P-selectin/IgM to peripheral blood leukocytes from (A)
WTRB6 mice or (B) Tpst DKORB6 mice. Shaded histograms represent
binding of CD45/IgM. Binding of the anti-Psgl-1 mAb 2PH1 to
peripheral blood leukocytes from (C) WTRB6 mice or (D) Tpst DKORB6
mice. Shaded histograms represent binding of isotype control mAb.
Panels A & C are same samples analyzed on the same day and are
representative of 3 WTRB6 mice. Panels B & D are also same samples
analyzed on the same day and are representative of 7 Tpst DKORB6
mice. All analyses were gated on the neutrophil and monocyte
population based on forward and orthogonal light scattering properties
and on donor origin (CD45.2
+).
doi:10.1371/journal.pone.0020406.g004
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and therefore blocks the action of all sulfotransferases [38]. They
reported that mutagenesis of Tyr13, but not Tyr15, to Phe or
incubation of cells with sodium chlorate impaired, but did not
abolish P-selectin binding and rolling of the transfected CHO cells.
Although this implicates Tyr13 as a potential site for sulfation,
these observations do not prove that Tyr13 is sulfated and that
Tyr15 is not, because Tyr to Phe substitution(s) might impair
function indirectly by altering the protein conformation or may
affect sulfate addition at the nearby non-mutated tyrosine. Thus,
further studies are necessary to directly determine the precise
location and stoichiometry of sulfation.
In summary, we examined the functional role for tyrosine
sulfation of mouse Psgl-1 using physiologically relevant assay
systems in a unique model in which mice were transplanted with
hematopoietic progenitors from mice lacking TPST activity. This
model enabled examination of mouse Psgl-1 function in a native
mouse leukocyte modified by endogenous mouse glycosyltransfer-
ases without altering the amino acid sequence of the protein. Our
studies provide direct and convincing evidence that tyrosine
sulfation is required for optimal function of mouse Psgl-1 in vivo.
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